Back to search

Article

The 10-year health impact, economic impact, and return on investment of the South African molecular diagnostics programme for HIV, Tuberculosis and SARS-CoV-2

2024-03-28

Abstract excerpt

<h4>ABSTRACT</h4> To ensure there is adequate investment into diagnostics, an understanding of the magnitude of impact and return on investment is necessary. We therefore sought to understand the health and economic impacts of the molecular diagnostic programme in South Africa, to deepen the understanding on the broad value of diagnostics and guide future healthcare investments. We calculated the 10-year (where da...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6b326c9b-6c66-5709-b4d0-79dc817946f0
DOI
10.1101/2024.03.27.24304888
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The 10-year health impact, economic impact, and return on investment of the South African molecular diagnostics programme for HIV, Tuberculosis and SARS-CoV-2DOI 10.1101/2024.03.27.24304888
Optimizing drug-resistant tuberculosis diagnosis: cost-effectiveness of rapid molecular and phenotypic assays in South Africa.Semantic proximity
The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South AfricaSemantic proximity
Cost-effectiveness and cost-utility of COVID-19 vaccination in a South African privately insured population: a real-world claims-based analysisSemantic proximity
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaSemantic proximity
Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of <i>Chlamydia trachomatis</i> , <i>Neisseria gonorrhoeae</i> and <i>Trichomonas vaginalis</i>Semantic proximity
Economic costs of accessing tuberculosis (TB) diagnostic services in Malawi: an analysis of patient costs from a randomised controlled trial of computer-aided chest x-ray interpretationSemantic proximity
Cost-effectiveness of GeneXpert Compared to Smear Microscopy for Diagnosis of Tuberculosis in EthiopiaSemantic proximity
Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysisSemantic proximity
Targeted genome sequencing for tuberculosis drug susceptibility testing in South Africa: A proposed diagnostic pipelineSemantic proximity
Improving testing capacity for COVID-19: Experiences and lessons from Senegal, Uganda, Nigeria and the Democratic Republic of CongoSemantic proximity
Cost-effectiveness of targeted next-generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysisSemantic proximity
Economic Burden and Return on Investment of Immunization Programs in Saudi Arabia: A Health Economic EvaluationSemantic proximity
Select a neighboring publication to make it the new centre.